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Recent studies suggest cone degeneration in retinitis pigmentosa (RP) may result from
intracellular energy depletion. We tested the hypothesis that cones die when depleted
of energy by examining the effect of two bioenergetic, nutraceutical agents on cone
survival. The study had three specific aims: firstly, we, studied the neuroprotective
efficacies of glucose and creatine in an in vitro model of RP. Next, we utilized a well-
characterized mouse model of RP to examine whether surviving cones, devoid of their
inner segments, continue to express genes vital for glucose, and creatine utilization.
Finally, we analyzed the neuroprotective properties of glucose and creatine on cone
photoreceptors in a mouse model of RP. Two different bioenergy-based therapies were
tested in rd1 mice: repeated local delivery of glucose and systemic creatine. Optomotor
responses were tested and cone density was quantified on retinal wholemounts. The
results showed that glucose supplementation increased survival of cones in culture
subjected to mitochondrial stress or oxidative insult. Despite losing their inner segments,
surviving cones in the rd1 retina continued to express the various glycolytic enzymes.
Following a single subconjunctival injection, the mean vitreous glucose concentration
was significantly elevated at 1 and 8 h, but not at 16 h after injection; however,
daily subconjunctival injection of glucose neither enhanced spatial visual performance
nor slowed cone cell degeneration in rd1 mice relative to isotonic saline. Creatine
dose-dependently increased survival of cones in culture subjected to mitochondrial
dysfunction, but not to oxidative stress. Despite the loss of their mitochondrial-rich
inner segments, cone somas and axonal terminals in the rd1 retina were strongly
positive for both the mitochondrial and cytosolic forms of creatine kinase at each
time point examined. Creatine-fed rd1 mice displayed enhanced optomotor responses
compared to mice fed normal chow. Moreover, cone density was significantly greater
in creatine-treated mice compared to controls. The overall results of this study provide
tentative support for the hypothesis that creatine supplementation may delay secondary
degeneration of cones in individuals with RP.
Keywords: rd1 mouse, retinitis pigmentosa, cone photoreceptor, bioenergetic neuroprotection, creatine,
nutraceutical, S-opsin, M/L-opsin
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INTRODUCTION
Human photoreceptors have a curious and incompletely
understood energy metabolism. They derive their nutrient supply
from the choriocapillaris, and recent evidence indicates that they
are members of a “metabolic ecosystem” comprising the retinal
pigment epithelium and adjacent Müller cells (Kanow et al.,
2017). Oxidative phosphorylation is an important source of ATP
for the retina (Anderson and Saltzman, 1964), and the region
of greatest oxygen consumption is the mitochondrial-rich inner
segments of the photoreceptors (Cringle et al., 2002). However,
mammalian photoreceptors also display aerobic glycolysis (the
Warburg effect), producing relatively large amounts of lactate
despite the presence of abundant oxygen (Winkler, 1981; Wang
et al., 1997; Chinchore et al., 2017; Narayan et al., 2017; Petit
et al., 2018). The explanation for this unusual metabolism,
which is reminiscent of cancer cells, is unclear, but it seems
reasonable to infer that photoreceptors are promiscuous in terms
of their energy supply.
Photoreceptors require large amounts of energy to maintain
their resting potentials (Ames et al., 1992; Niven et al., 2007),
with cones incurring an even greater energy expenditure
than rods (Okawa et al., 2008). In the face of this relentless
energy demand it seems likely that an impairment of
energy metabolism would be detrimental to photoreceptor
function with serious consequences for vision. Indeed, there
is converging evidence that bioenergetic dysfunction is a key
pathogenic factor in secondary cone degeneration in retinitis
pigmentosa (RP) (Punzo et al., 2009; Ait-Ali et al., 2015;
Narayan et al., 2016; Wang et al., 2016). In the majority of
subtypes of RP, the genetic defect is expressed in the rods,
but in most individuals the cones eventually degenerate
resulting in loss of central vision. Therapeutic targeting of
secondary cone degeneration in RP is a broad-spectrum
strategy applicable to a large proportion of RP subtypes
irrespective of the specific gene defect. Bioenergetic-based
neuroprotection strategies, which include augmenting or
conserving available energy supplies, boosting mitochondrial
efficiency, and improving cellular energy-buffering, and offer
great potential in RP. Nutraceutical approaches to bioenergetic
neuroprotection gain further appeal by their relative safety and
clinical translatability.
Recent studies in animal models of RP have demonstrated
that high glucose is critical for cone survival and that reduced
glucose entry into cones triggers their degeneration (Punzo et al.,
2009; Ait-Ali et al., 2015; Venkatesh et al., 2016). Moreover, a
single injection of glucose has been shown to cause a short-
term improvement in cone morphology in a slow-progressing
porcine model of RP (Wang et al., 2016). We have previously
demonstrated that elevating the vitreal glucose level protects
retinal ganglion cells against experimental ischemic injury
(Casson et al., 2004; Shibeeb et al., 2016) and temporarily recovers
contrast sensitivity in individuals with glaucoma (Casson et al.,
2014; Shibeeb et al., 2016). Importantly, these effects can be
achieved by local delivery of glucose. These insights provide
considerable motivation to further investigate glucose energy
supplementation as a potential therapy for RP.
A second bioenergetic approach with potential applicability
to RP involves boosting levels of the nutraceutical creatine in
cones. The creatine kinase/phosphocreatine system, plays an
important role in mitochondrial energy metabolism (Wallimann
et al., 2011), particularly in cells with high energetic demands
such as photoreceptors (Linton et al., 2010). Functions ascribed
to the creatine kinase/phosphocreatine kinase system include
spatiotemporal buffering of ATP and improving the efficiency
of oxidative phosphorylation. The creatine transporter, which is
responsible for creatine uptake into cells, and creatine kinase,
which catalyzes the reversible conversion of creatine into high
energy phosphocreatine, are both expressed in photoreceptors
(Acosta et al., 2005; Linton et al., 2010; Rueda et al., 2016;
Chidlow et al., 2019); thus, supplementation with creatine is a
neuroprotective strategy worthy of investigation.
The present study had three objectives: firstly, we, studied
the neuroprotective efficacies of glucose and creatine in an
in vitro model of RP. Next, we utilized a well-characterized mouse
model of RP to examine whether surviving cones, devoid of
their inner segments, continue to express genes vital for glucose
and creatine utilization. Finally, we analyzed the neuroprotective
properties of glucose and creatine on cone photoreceptors in the
mouse model of RP.
MATERIALS AND METHODS
Retinal Cells in vitro: Establishment,
Treatment, and Analysis of Cultures
Retinal cultures consisting of a mixed population of cell-types
were established from 2 to 4 day old Sprague-Dawley rat pups via
a combined enzymatic and mechanical dissociation procedure,
as described previously (Wood et al., 2012). Dissociated cells
were seeded on borosilicate glass coverslips pre-coated with
poly-L-lysine (10 µg/ml; 15 min), at 0.5 × 106 cells/ml, in
Minimal Essential Medium (Life Technologies Australia Pty
Ltd, Mulgrave, VIC, Australia), containing 100 U/mL penicillin
and streptomycin, 2 mM L-glutamine, 5 mM D-glucose and
10% (v/v) fetal bovine serum. Cultures were grown for 6 days
in vitro, with no medium change during this time. Importantly,
immunolabeling of cultures demonstrated the presence of
S-opsin-expressing cone photoreceptors (Figure 1), enabling
investigation of the responses of these cells to stressors and
potential protectants in vitro.
Prior to experimental treatments, cultures were changed
into an equivalent medium containing no glucose for 24 h;
metabolic activity of cells was maintained by the presence
of L-glutamine (Wood et al., 2005). For assessment of the
potential protective effects of glucose (5 mM) or creatine (0.5
and 5 mM), cultures were pretreated for an additional 24 h
with these compounds. To establish oxidative stress, tert-butyl
hydroperoxide (tbH; 50 – 250 µM) was applied to cultures for
24 h. To induce metabolic stress, the mitochondrial Complex IV
inhibitor sodium azide (250 µM – 1 mM) was applied for 24 h.
All stressors and protectants were soluble in cell culture medium
and hence, where applied, “vehicle” refers to an added equivalent
volume of medium. After treatments, cultures were fixed in 10%
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(w/v) neutral buffered formalin for 15 min and then processed
for cone photoreceptor analysis via immunocytochemistry.
A schematic representing the experimental timeline is provided
in Supplementary Figure S1.
To assess if sodium azide increased aerobic glycolysis in mixed
retinal cultures, cultures were changed into serum-free medium
and incubated for 3 h in the presence or absence of sodium azide.
Aliquots of medium were then analyzed using a lactate assay kit
(BioVision Inc., Milpitas, CA, United States) and absorbances
read with a microplate reader (Fluostar Optima; BMG Labtech,
Mornington, VIC, Australia).
Survival of cones was assessed by immunocytochemical
labeling of fixed cultures with S-opsin antibody (1:1000,
see Table 1), as described in the immunohistochemistry
methods section below. Nuclear counter-staining of cells
was achieved with a final 5 min incubation of coverslips
in 500 ng/ml 4′,6-diamidino-2-phenylindole (DAPI) before
washing and mounting.
Animals and Procedures
This study was approved by the Animal Ethics Committees of
SA Pathology/Central Adelaide Local Health Network (CALHN)
and the University of Adelaide (Adelaide, SA, Australia) and
conformed with the Australian Code of Practice for the Care
and Use of Animals for Scientific Purposes, 2013, and with the
ARVO Statement for the use of animals in vision and ophthalmic
research. C3H/HeJArc (rd1) mice and C57BL/6J (wild-type, WT)
mice were obtained from the Animal Resources Centre (Perth,
WA, Australia). The C3H/HeJArc mouse is an inbred strain
homozygous for the PDE6b mutation. rd1 mice were inbred to
produce offspring. All animals were housed in a temperature
and humidity-controlled room with a 12-h light/dark cycle and
provided with food and water ad libitum.
For detection of cone opsin proteins, creatine kinase isoforms,
and glycolytic enzymes by immunohistochemistry, rd1 mice at
various postnatal day (P) time points [P7, P14, P21, P30, P45, and
P60 (all n = 3) and WT mice (C57BL/6, n = 3)] were analyzed.
For the glucose neuroprotection study, rd1 mice were
randomly divided into experimental (n = 13) and control (n = 11)
groups. At the starting age of P14, the right eyes of experimental
mice were treated with an injection of 20 µl of 50% glucose into
the subconjunctival space (see below). Injections were repeated
at 24-hourly intervals. The left eye remained as an untreated
control. Mice in the control group received a subconjunctival
injection of osmotically matched 8.4% saline. Again, the fellow
eye served as an untreated control. Injections were continued for
30 days in both groups. Optomotor testing was performed 10 days
into the treatment regimen at P24. Mice were euthanized at P60.
For the creatine neuroprotection study, rd1 mice were
randomly divided into experimental (n = 21) and control (n = 18)
groups. The experimental group was placed on a 2% oral
creatine diet starting at the age of P21. Mice litters were weaned
from their parents at P21 and this was the age oral treatment
with creatine was commenced. Control animals were given an
equicaloric standard mouse diet, without creatine. Mice were
carefully observed to monitor their eating. Because the creatine
was incorporated in the food, and mice were kept at 4 – 5 per
cage, it was difficult to accurately assess how much food each
mouse consumed. Daily weighing of mice was performed, and
satisfactory weight gain was used as an indicator of appropriate
food consumption. Optomotor testing was performed at P30.
Mice in experimental and control groups continued their diet
until they were euthanized at P60.
Tissue Processing and
Immunohistochemistry
All mice were euthanized by transcardial perfusion with
physiological saline under deep anesthesia. The superior
aspect of each cornea was marked for orientation before
globes were enucleated. For double labeling wholemount
immunohistochemistry, eyes were fixed in 4% (w/v) neutral
buffered formalin for 24 h and dissected into posterior eye-cups.
Retinas were removed and prepared as flattened wholemounts
by making another four radial cuts. Retinas were then incubated
in phosphate buffered saline (PBS) containing 1% Triton X-100
detergent (PBS-T) for 1 h at room temperature. Next, retinas
were incubated in PBS-T containing 3% normal horse serum
(NHS-T) for 1 h at room temperature to block non-specific
antibody binding. Retinas were then incubated overnight at
4◦C with a combination of anti-S-opsin and anti-M/L-opsin
antibodies diluted in NHS-T (see Table 1). On day 2, retinas were
washed for 1 h at room temperature in PBS-T, then incubated
overnight at 4◦C with a combination of AlexaFluor-488 and -594
conjugated secondary antibodies (1:250; Invitrogen, Carlsbad,
TABLE 1 | Primary antibodies used in the study.
Protein Source Cat. No. Species Immunogen Dilution
CK-B Abcam Ab125114 Mouse Synthetic peptide SNSHNALKLRFPAEDEF, corresponding to N
terminal amino acids 4–20 of human creatine kinase B type
1:1000
CK-MT1A Proteintech 15346-1-AP Rabbit CKMT1A fusion protein Ag7583 1:5,000
Hexokinase II Cell Signaling
Technology
2867 Rabbit Synthetic peptide corresponding to the sequence of human
hexokinase II
1:500
LDH-A Santa-Cruz sc-27230 Goat Epitope mapping at the N-terminus of LDH-A of human origin 1:1000
M/L-opsin Merck-Millipore AB5405 Rabbit Recombinant human red/green opsin 1:1500
S-opsin Santa-Cruz sc-14363 Goat Peptide mapping at the N-terminus of the opsin protein
encoded by OPN1SW of human origin
1:1500
LDH-A, lactate dehydrogenase subunit A; CK-B, creatine kinase B-type; CK-MT1A, creatine kinase mitochondrial 1A.
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CA, United States) diluted in NHS-T. Finally, retinas were
washed in PBS for 1 h at room temperature prior to mounting
with the photoreceptor side facing up using anti-fade mounting
medium (Dako, CA, United States).
For immunohistochemistry on transverse sections, globes
were immersion-fixed in Davidson’s solution for 24 h and
transferred to 70% ethanol until processing. Davidson’s solution,
which comprises 2 parts formaldehyde (37%), 3 parts 100%
ethanol, 1 part glacial acetic acid and 3 parts water, is the
preferred fixative for whole eyes as it provides optimal tissue
morphology while avoiding retinal detachment. Globes were
embedded sagittally and 4 µm serial sections were cut. For
fluorescent double labeling immunohistochemistry, visualization
of one antigen was achieved using a 3-step procedure, while
the second antigen was labeled by a 2-step procedure, as
previously described (Chidlow et al., 2011, 2016). In brief,
tissue sections were deparaffinized and high-temperature
antigen retrieval was performed. Subsequently, sections
were incubated overnight in the appropriate combination
of primary antibodies (Table 1). On the following day,
sections were incubated with the appropriate biotinylated
secondary antibody (1:250) for the 3-step procedure plus
the correct secondary antibody conjugated to AlexaFluor
488 (1:250; Invitrogen) for the 2-step procedure for 30 min,
followed by streptavidin-conjugated AlexaFluor 594 (1:500;
Invitrogen) for 1 h. Sections were then mounted using anti-fade
mounting medium.
Image Acquisition and Quantification
Confirmation of the specificity of antibody labeling was judged
by the morphology and distribution of the labeled cells,
by the absence of signal when the primary antibody was
replaced by isotype/serum controls, and, by comparison with
the expected staining pattern based on our own, and other,
previously published results. Retinal wholemounts and transverse
sections were examined under a fluorescence microscope (BX-
61; Olympus, Mount Waverly, VIC, Australia) equipped with a
scientific grade, cooled CCD camera.
Photomicrographs measuring 720 µm x 540 µm were taken
using the fluorescence microscope on whole mounts retinas.
Four photomicrographs of the central retina were taken directly
superior, temporal, inferior, and nasal to the center of the optic
nerve. Four photomicrographs of the peripheral retina were taken
1.5 mm superior, temporal, inferior, and nasal to the center of
the optic nerve. This yielded a total of 16 photomicrographs
per retina. Quantification of cone survival was performed using
Image-J software (NIH, Bethesda, MD, United States). Initially,
however, images were processed in Photoshop CS3 (Adobe, San
Jose, CA, United States) for uneven lighting (using a flatten filter),
sharpened, levels enhanced, and finally converted to 8-bit mode.
For the glucose experiment, three statistical comparisons
were performed: glucose-injected vs. untreated contralateral
eyes (Student’s paired t-test); saline-injected vs. untreated
contralateral eyes (Student’s paired t-test); saline-injected eyes vs.
glucose-injected eyes (Student’s unpaired t-test). For the creatine
experiment, statistical analysis was carried out by Student’s
unpaired t-test. The null hypothesis tested in each case was
that cone density would be significantly higher in experimental
vs. control eyes.
Measurement of Vitreal and Retinal
Glucose After Subconjunctival Injection
Subconjunctival drug administration bypasses the conjunctival
epithelial barrier, which is a rate-limiting factor for the
permeation of water-soluble drugs (Gaudana et al., 2010);
however, various dynamic, static, and metabolic barriers limit
drug access to the posterior segment and retina. In order to
establish whether subconjunctival glucose reaches the retina, a
preliminary investigation was performed to measure the vitreous
glucose concentration after subconjunctival injection. A single
injection of 20 µl of 50% glucose was administered into the
subconjunctival space in the right eyes of C57BL/6J mice.
This procedure involved lifting the inside of the eyelid with
fine forceps and delivering a subconjunctival injection using
a 33G needle. Use of an operating microscope facilitated the
procedure. Injections were performed under isoflurane sedation
and topical amethocaine 0.5% anesthetic. During every injection,
visualization of a subconjunctival bleb provided confirmation
that the injection had been successfully administered. Left eyes
were treated with an injection of osmotically matched 8.4% saline.
Mice were euthanized after 1, 8, and 16 h (n = 3 per time point).
Eyes were enucleated, the vitreous was removed as described
previously (Skeie et al., 2011) and then sonicated. Vitreal samples
(diluted to a final volume of 100 µl with distilled water) were
then analyzed using a glucose hexokinase assay kit (Sigma-
Aldrich Corp., St Louis, MO, United States) and absorbances read
with a microplate reader (Fluostar Optima). The final vitreous
glucose concentration (mmol/L) was determined by allowing for
the 10-fold dilution factor, and comparing the absorbance with
a previously constructed calibration curve. Statistical analysis
was carried out by Student’s paired t-test with Holm-Bonferroni
correction. The null hypothesis tested was that the vitreous
glucose concentration would be significantly higher in glucose-
vs. saline-injected eyes.
A further experiment (n = 3) was carried out in which both the
vitreal and retinal concentration of glucose was measured 30 min
after a single subconjunctival injection of 20 µl of 50% glucose,
using the method detailed above.
To analyze retinal uptake of 2-NBDG, mice underwent
a single subconjunctival injection of 20 µl of 10 mM 2-
NBDG (Invitrogen, Carlsbad, CA, United States) dissolved in
water. After 30 min, mice were euthanized by exposure to
a rising concentration of CO2 and globes were enucleated
under red light. They were then snap frozen in dry ice-
cooled isopentane. Frozen, vertical sections (10 µm) were taken,
mounted using anti-fade mounting medium, and examined
under a fluorescence microscope.
Optomotor Testing
This test measures the tendency of an animal to follow a
moving object using their head and eyes. Optomotor testing is
an established method for quantifying visual function in mice
(Prusky et al., 2004). The room was darkened for testing. The
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only illumination came from the LED screens of the optomotor
cage. However, animals were light adapted before starting the
test, i.e., they were tested under photopic conditions. Mice were
placed on a platform positioned in the middle of an arena
created by a quad square of computer monitors. Vertical sine
wave gratings (100% contrast) were projected on the computer
monitors. The spatial frequencies tested were 0.05, 0.075, 0.1,
0.2, 0.3, 0.4, 0.5, and 0.6 cycles per degree, at a constant speed
of 12 degrees/s. A camera was positioned directly above the
platform in order to observe the animal’s head movements.
Mice were placed one at a time on the platform and allowed to
move freely while the experimenter followed the mouse’s head.
When a grating perceptible to the mouse was projected on the
cylinder wall and the cylinder was rotated (12 degrees/s), the
mouse normally stopped moving its body and would begin to
track the grating with reflexive head movements in concert with
the rotation. A recorder assessed whether the mice tracked the
cylinder by monitoring in the video window the image of the
cylinder and the animal simultaneously. The spatial frequency
of the grating was systematically increased the until the animal
no longer responded. The process of incrementally changing the
spatial frequency of the test grating was repeated until the highest
spatial frequency that the mouse could track was identified as the
threshold. A threshold for each direction of rotation was assessed
this way, and the highest spatial frequency tracked in either
direction was recorded as the threshold. Recorders were blinded
to the treatment group and all mice were habituated before the
outset of testing. For the glucose experiment, three statistical
comparisons were performed: glucose-injected vs. untreated
contralateral eyes (Student’s paired t-test); saline-injected vs.
untreated contralateral eyes (Student’s paired t-test); saline-
injected eyes vs. glucose-injected eyes (Student’s unpaired t-test).
For the creatine experiment, statistical analysis was carried out
by Student’s unpaired t-test. The null hypothesis tested in each
FIGURE 1 | Effect of glucose on stressor-induced S-opsin-labeled cone loss from mixed retinal cell cultures. Representative images from untreated (A),
vehicle-treated (C,E,G) or glucose (5 mM)-treated (B,D,F,H) cultures additionally exposed to (C,D), 100 µM tbH (E,F), 500 µM sodium azide (G,H), 1 mM sodium
azide. These data are followed by graphs quantifying the positive effect of glucose on tBH-induced (I) and sodium azide-induced (J) cone cell loss. It is evident that
both tbH and sodium azide are markedly destructive to S-opsin labeled cones in culture and that glucose has clear protective influences on these cells in both
cases. Values represent mean ± SEM, where n = 8 determinations from separate cultures. ∗∗P < 0.01, and ∗P < 0.05 by Student’s paired t-test with
Holm-Bonferroni correction. Scale bar, 50 µm.
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case was that visual function would be significantly greater in
experimental vs. control eyes.
RESULTS
Glucose Supplementation Protects
Cones in Culture From Mitochondrial
Dysfunction and Oxidative Injury
In order to investigate responses and potential protection
of cone cells in culture, they were treated with one of
two stressors: (1) sodium azide, which in inhibiting
mitochondrial Complex IV causes metabolic compromise
and (2) tbH, which induces intracellular oxidative stress.
Both stressors mimic aspects of the pathology believed
to be associated with RP (Narayan et al., 2016). Of
note, sodium azide, by reducing mitochondrial activity,
causes a compensatory increase in glycolysis, which is
evidenced by increased lactate in the culture medium
(Supplementary Figure S1).
Initially, we tested the protective effects of enriching the
culture medium with 5 mM glucose; data are shown in Figure 1.
Treatment with tbH caused a concentration-dependent loss of
S-opsin cones with no observed decrease when 50 µM was
applied, but with only 38.7 ± 5.9% or 12.0 ± 5.1% of cells
remaining, respectively, when 100 µM or 250 µM tbH were
applied. The presence of 5 mM glucose in the medium for
24 h prior to application of tbH was significantly protective:
104.0 ± 14.1% and 50.1 ± 11.1% of the control cell number
FIGURE 2 | (A) Quantification of the vitreous glucose concentration in C57BL/6J mice at 1 to 16 h after subconjunctival injection of either glucose or saline. Values
represent mean ± SEM, where n = 3. ∗∗P < 0.01, ∗P < 0.05 by Student’s paired t-test with Holm-Bonferroni correction. (B–G) 2-NBDG accumulation in C57BL/6J
mice retinas 20 min after subconjunctival injection. In the control mouse, minimal fluorescence is observed (B–D). In the 2-NBDG injected eye, fluorescent glucose
accumulates in photoreceptor segments and, to a lesser extent, in both plexiform layers (E–G). Scale bar: 50 µm. GCL, ganglion cell layer; INL, inner nuclear layer;
IS, inner segments; ONL, outer nuclear layer; and OS, outer segments.
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remained when cultures were treated with 100 µM and 250 µM
tbH, respectively, in the presence of glucose (Figure 1).
Mitochondrial dysfunction, as induced by treatment of
cultures with sodium azide for 24 h, caused a concentration-
dependent loss of cones, with no significant loss when 250 µM
was applied (93.1 ± 9.6% of control value), but significant
decreases noted when 500 µM (20.7 ± 5.0% of control) or
1 mM (9.2 ± 4.0% of control) were applied (Figure 1). Pre-
treatment with glucose significantly reduced the loss of cones
with 81.6 ± 11.3% and 55.2 ± 12.3% of cones remaining after
treatment with 500 µM and 1 mM azide, respectively.
Subconjunctival Delivery of Glucose
Elevates the Vitreous Glucose
Concentration
Prior to examining whether daily injections of glucose delay
cone degeneration in a mouse model of RP, it was important to
ascertain whether the delivery strategy resulted in a detectable
increase in the level of glucose available to the retina. Thus,
we measured the vitreous glucose concentration at time points
after single subconjunctival injections of glucose or osmotically
matched saline in WT mice. The results revealed statistically
significant upregulations of glucose in the treated eye, compared
to the saline-injected contralateral eye, at 1 h (P < 0.01, by paired
Student’s t-test) and 8 h (P < 0.05), but not 16 h, after injection
(Figure 2A). Next, we part-repeated the experiment, except on
this occasion we measured the retinal, as well as vitreal, glucose
concentration at 1 h after injection, the time point of maximal
elevation. In the vitreous, the glucose injected eye contained
9.8 ± 0.7 mmol/l glucose, which was significantly (P < 0.01 by
Student’s unpaired t-test) higher than the untreated contralateral
eye (2.3 ± 0.2). In the retina, the glucose injected eye contained
38.3 ± 14.4 µg/retina glucose, whilst the untreated contralateral
eye contained 16.0 ± 6.7 µg/retina glucose, a difference that
did not reach statistical significance (P > 0.1). Of note, it is
not possible for us to rule out that each retinal sample was
contaminated by vitreous. In the mouse, the vitreous adheres
to the retina tightly and this may have contributed to the
trend of an elevated concentration in the retinal sample of the
glucose injected eye.
In order to ascertain whether glucose reaches the
photoreceptors after subconjunctival injection, we utilized
2-deoxy glucose (2-NDBG), a stable, fluorescent glucose
derivative used for monitoring glucose uptake into living
cells (Kanow et al., 2017). At 30 min after subconjunctival
injection of 10 mM 2-NDBG, we harvested the retina for tissue
sectioning and fluorescent imaging. Figures 2B–G reveals that
2-NBDG fluorescence was weakly localized to the inner and
outer plexiform layers and was stronger in the photoreceptor
inner and outer segments, confirming that glucose reaches the
photoreceptor layer after subconjunctival injection.
Surviving Cones in the rd1 Retina
Express Glycolytic Enzymes
Photoreceptors have a high glycolytic flux and rate of lactate
production even in the presence of oxygen, a phenomenon
known as aerobic glycolysis. Accordingly, photoreceptors
express glycolytic isoenzymes associated with aerobic glycolysis,
including hexokinase II, pyruvate kinase M2 and lactate
dehydrogenase (LDH). An increasing body of evidence suggests
that energy starvation contributes to secondary degeneration of
cones in RP (Punzo et al., 2009; Petit et al., 2018). Since glycolytic
enzymes are concentrated in photoreceptor inner segments, and
since loss of cone segments is an early pathological event in
RP, we investigated whether surviving cones in the rd1 retina
continue to express genes vital for glucose utilization, including
hexokinase II and lactate dehydrogenase subunit A (LDH-A).
In WT retinas, hexokinase II labeling was essentially restricted
to rod and cone photoreceptor inner segments (Figures 3A–C).
Despite the loss of inner segments, surviving cones in the
rd1 retina were strongly positive for hexokinase II at all time
points examined, encompassing P7 to P60 (see Figures 3D–L for
representative images).
In WT retinas, LDH-A was expressed by rod and cone
photoreceptor somas, inner segments and axonal terminals, plus
a limited number of cells in the inner retina (Figures 4A–C). In
the rd1 retina, LDH-A labeling was unequivocally expressed by
surviving cones at each time point examined, encompassing P7
to P60 (see Figures 4D–L for representative images).
FIGURE 3 | Representative double labeling immunofluorescence images of
hexokinase II with S-opsin in wild-type (WT) mouse retina and in Rd1 mouse
retinas from postnatal day (P) 14 to P60. (A–C) In WT retinas, hexokinase II is
essentially restricted to rod and cone photoreceptor inner segments. (D–F) At
P14, hexokinase II colocalizes with S-opsin in shrunken inner segments
(arrow) and weakly labels occasional cone somas. (G–L) From P30 to P60,
the ONL comprises a single layer of surviving cones largely devoid of
segments. Hexokinase II colocalizes with S-opsin in cone somas (arrows). All
images were captured from the inferior retina, which comprises primarily
S-cones. INL, inner nuclear layer; IS, inner segments, ONL, outer nuclear
layer; RPE, retinal pigment epithelium. Scale bar: 20 µm.
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FIGURE 4 | Representative double labeling immunofluorescence images of
LDH-A with M/L-opsin in wild-type (WT) mouse retina and in Rd1 mouse
retinas from postnatal day (P) 14 to P60. (A–C) In WT retinas, LDH-A is
associated with rod and cone photoreceptor somas, inner segments and
axonal terminals, together with cells in the inner retina. (D–F) At P14,
hexokinase II colocalizes with M/L-opsin in shrunken inner segments (arrow)
and weakly labels photoreceptor somas and axonal terminals. (G–L) From
P30 to P60, the ONL comprises a single layer of surviving cones largely
devoid of segments. LDH-A is observed in surviving cone somas (arrows). All
images were captured from the superior retina, which comprises primarily
M/L-cones. INL, inner nuclear layer; IS, inner segments, ONL, outer nuclear
layer; RPE, retinal pigment epithelium. Scale bar: 20 µm.
In addition to hexokinase II and LDH-A, surviving cones also
displayed PKM2 and neuron-specific enolase immunoreactivities
(data not shown). The overall data indicate that despite losing
their inner segments, surviving cones in the rd1 retina retain their
complement of enzymes necessary to metabolize glucose.
Subconjunctival Delivery of Glucose
Does Not Preserve Cones in rd1 Retinas
rd1 mice received a daily unilateral injection of glucose or
osmotically matched saline for 30 days. After 10 days of
injections, their visual acuity was assessed using the optomotor
reflex test. Both the saline-injected and glucose-injected groups
displayed modestly enhanced optomotor responses compared
to their respective contralateral eyes (Figure 5), although
only the saline-injected group reached statistical significance
(P < 0.01, by paired Student’s t-test). Importantly, there was
no difference between the glucose-injected and saline-injected
groups (P = 0.25, by unpaired Student’s t-test).
At P60, the number of surviving cones were quantified.
Mouse retinas contain three types of cones, short wavelength
light-responsive S-cones, medium to long wavelength light-
responsive M/L-cones, and a majority of dual cones that express
both opsins (Applebury et al., 2000; Haverkamp et al., 2005;
Ortin-Martinez et al., 2014). In the rd1 mouse, degeneration
FIGURE 5 | Performance of Rd1 mice in the optomotor tracking test
undertaken at P24, following 10 days of treatment. Rd1 mice received a daily
unilateral subconjunctival injection of glucose or saline; the respective
contralateral eyes were untreated. Values represent mean ± SEM, where
n = 11–13. ∗P < 0.05 by Student’s paired t-test (saline-injected vs. untreated
contralateral eyes). There were no significant differences between
glucose-injected and untreated contralateral eyes (Student’s paired t-test) or
between saline-injected eyes and glucose-injected eyes (Student’s unpaired
t-test).
of cones is more rapid in the central than peripheral retina
(Carter-Dawson et al., 1978; Lin et al., 2009). Figures 6A–P,
7A–P, respectively, feature representative images of S-opsin+
and M/L-opsin+ cones from the different treatment groups. The
photomicrographs highlight the central to peripheral divergence
in cone survival in the rd1 retina. The photomicrographs also
reveal that, at P60, M/L-opsin+ cones are more numerous
in the superior retina relative to the inferior retina, whereas
S-opsin+ cones are far more numerous in the inferior retina.
This hemispheric asymmetry in S-opsin+ and M/L-opsin+ cone
expression is in agreement with earlier findings (Lin et al., 2009;
Narayan et al., 2019). The very low numbers of M/L-opsin+
cones in the inferior retina does not necessarily indicate that dual
cones are preferentially lost in the inferior retina, instead it likely
reflects the fact that M/L-opsin protein expression is intrinsically
very much lower in cones in the inferior retina as compared to
the superior retina (Applebury et al., 2000; Haverkamp et al.,
2005). With the loss of their outer segments – which contain
extraordinarily high levels of opsins – M/L-opsin is no longer
detectable in dual cone somas and pedicles, which appear as
apparent S-cones. The low numbers of S-opsin+ cones in the
superior retina simply reflects the fact that there are far fewer
S-opsin+ cones in the superior as compared to inferior retina.
Quantification of the density of S-opsin+ and M/L-opsin+ cones
in the whole retina showed a trend of higher counts of both
cone types in each of the saline-injected and glucose-injected
groups when compared to their respective, paired, contralateral
eyes (Figures 6Q, 7Q), although only the saline-injected group
M/L-opsin+ cone count reached statistical significance (P < 0.05,
by paired Student’s t-test). As for the optomotor testing, there
was no significant difference between the number of S-opsin+
cones or M/L-opsin+ cones in the glucose-injected vs. saline-
injected cohorts (P = 0.25, by unpaired Student’s t-test). When
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FIGURE 6 | Effect of daily glucose injections on S-opsin+-cone survival. (A–P) Photomicrographs of wholemount Rd1 retinas analyzed at postnatal day (P) 60
immunolabeled for S-opsin. Representative images from glucose-injected eyes (A–D) and the respective contralateral untreated eyes (E–H), saline-injected eyes
(I–L), and the respective contralateral untreated eyes (M–P) are shown. S-P, superior-peripheral retina; S-C, superior-central retina; I-C, inferior-central retina; I-P,
inferior-peripheral retina. Scale bar 100 µm. (Q–S) Quantification of S-opsin-labeled cones in retinal wholemounts from Rd1 mice treated with daily unilateral
subconjunctival injections of glucose or saline, and in the respective untreated contralateral eyes. Data are shown for the whole retina (Q), subdivided into central
(R), and peripheral (S) regions. Values, shown as % of the untreated saline group, represent mean ± SEM, where n = 11–13. There were no significant differences
between glucose-injected and untreated contralateral eyes (Student’s paired t-test), saline-injected vs. untreated contralateral eyes (Student’s paired t-test), or
between saline-injected eyes and glucose-injected eyes (Student’s unpaired t-test).
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FIGURE 7 | Effect of daily glucose injections on M/L-opsin+-cone survival. (A–P) Photomicrographs of wholemount Rd1 retinas analyzed at postnatal day (P) 60
immunolabeled for M/L-opsin. Representative images from glucose-injected eyes (A–D) and the respective contralateral untreated eyes (E–H), saline-injected eyes
(I–L) and the respective contralateral untreated eyes (M–P) are shown. S-P, superior-peripheral retina; S-C, superior-central retina; I-C, inferior-central retina; I-P,
inferior-peripheral retina. Scale bar 100 µm. (Q–S) Quantification of S-opsin-labeled cones in retinal wholemounts from Rd1 mice treated with daily unilateral
subconjunctival injections of glucose or saline, and in the respective untreated contralateral eyes. Data are shown for the whole retina (Q), subdivided into central
(R), and peripheral (S) regions. Values, shown as % of the untreated saline group, represent mean ± SEM, where n = 11–13. ∗P < 0.05 by Student’s paired t-test
(saline-injected vs. untreated contralateral eyes). There were no significant differences between glucose-injected and untreated contralateral eyes (Student’s paired
t-test) or between saline-injected eyes and glucose-injected eyes (Student’s unpaired t-test).
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the data were subdivided into central (Figures 6R, 7R) and
peripheral (Figures 6S, 7S) regions, the same patterns of cone
survival were evident, namely a non-significant trend of higher
counts of both cone types in each of the saline-injected and
glucose-injected groups when compared to their respective
contralateral eyes. As for the pan retinal quantification, there was
no significant difference between the glucose-injected vs. saline-
injected cohorts in survival of either cone type in the central or
peripheral retina regions of the retina.
Creatine Supplementation Protects
Cones in Culture From Mitochondrial
Dysfunction but Not Oxidative Injury
The effect of a creatine on survival of cones after induction of
stress in vitro was assessed after a 24-h pre-treatment. Similar
to the glucose experiments shown in Figure 1, tbH application
caused a reduction to 37.9 ± 7.2% and 6.0 ± 3.0% of the
control cell number when applied at 100 µM or 250 µM,
respectively (Figure 8). Creatine pre-treatment (0.5 or 5 mM)
had no significant effect on promoting additional survival of cells
treated with tbH.
Sodium azide also caused a concentration-dependent loss of
S-opsin-labeling cones from mixed retinal cell cultures: 44± 8.9%
and 10.7 ± 2.7% of the control cell number of cones remained
after application of 500 µM and 1 mM sodium azide, respectively
(Figure 8). In this case, pre-treatment with creatine at the
concentration of 0.5 mM was also not protective to cells, however,
when applied at 5 mM, this compound did offer significant
protection: there were 85.3 ± 11.0% and 56.0 ± 15.2% of the
control number of cells remaining after treatment with 500 µM
and 1 mM sodium azide, respectively (Figure 8).
Surviving Cones in the rd1 Retina
Express Creatine Kinase Isoenzymes
The creatine kinase/phosphocreatine system functions as a
spatial and temporal energy buffer in cells, linking sites of
FIGURE 8 | Effect of creatine on stressor-induced S-opsin-labeled cone loss from mixed retinal cell cultures. Representative images from untreated (A),
vehicle-treated (C,E,G) or creatine (5 mM)-treated (B,D,F,H) cultures additionally exposed to (C,D), 100 µM tbH (E,F), 500 µM sodium azide (G,H), 1 mM sodium
azide. These data are followed by graphs quantifying the effect of creatine on tBH-induced (I) and sodium azide-induced (J) cone cell loss. It is evident that both tbH
and sodium azide cause marked loss of S-opsin labeled cones in culture. It is further clear that although creatine has no effect on the cone loss induced by tbH, it is
able to significantly protect these cells from sodium azide-induced toxicity. Values represent mean ± SEM, where n = 8 determinations from separate cultures.
∗∗P < 0.01, by one way ANOVA, followed by Dunnett’s multiple comparisons test. Scale bar, 50 µm.
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energy production, and utilization. Typically, mitochondrial
creatine kinase (MT-CK1A) converts creatine to high energy
phosphocreatine at sites of ATP production, generating a
diffusible energy substrate, whilst the cytoplasmic isoform
(CK-B) catalyzes the reverse reaction at subcellular locations
of energy usage (Wallimann et al., 2011). Before investigating
whether augmenting retinal creatine delays cone loss in
the rd1 retina, it was important to ascertain whether
the enzymes of the creatine-phosphocreatine system are
preserved in surviving cones of the rd1 retina during
the period of cone degeneration. This is important since
mitochondrial creatine kinase is principally localized in
photoreceptor inner segments.
In WT mouse retina, CK-MT1A was present in rod and cone
inner segments, in cone but not rod somas in the outer nuclear
layer, and in photoreceptor terminals in the outer plexiform layer
(Figures 9A–C). The pattern of expression at P7 was similar to
WT (Figures 9D–F). By P14, rod death is quite advanced and
CK-MT1A colocalizes with S-opsin in shrunken inner segments,
cone somas and axonal terminals (Figures 9G–I). Despite the
loss of inner segments from P21, surviving cone somas and
axonal terminals in the rd1 retina were strongly positive for CK-
MT1A at all time points examined, encompassing P7 to P60
(Figures 9J–R). Labeling of cone cell bodies for CK-MT1A was
considerably stronger than at P7 or in WT retinas.
In WT mouse retina, CK-B was present in cone but not rod
inner segments and in terminals in the outer plexiform layer
(Figures 10A–C). From these results, it might be inferred that
creatine kinase plays a greater role in cones compared with rods.
As for CK-MT1A, surviving cones in the rd1 retina were positive
for CK-B at all time points examined, encompassing P7 to P60
(see Figures 10D–L). Unlike the WT retina, in which cone somal
labeling of CK-B was undetectable, from P21 onward cone cell
bodies were clearly positive for CK-B.
Dietary Creatine Supplementation
Augments Cone Survival in Rd1 Retinas
rd1 mice received either normal chow or 2% oral creatine
diet starting at P21. Optomotor testing was performed at
P30, the results of which revealed that the creatine-enriched
group exhibited approximately 4.5-fold greater visual acuity
compared to the control diet cohort (P < 0.01, by unpaired
Student’s t-test; Figure 11). At P60, the number of surviving
cones were quantified. Figures 12A–P shows representative
photomicrographs of S-opsin+ and M/L-opsin+ cones
from each treatment group. Quantification of the density
of S-opsin+ and M/L-opsin+ cones in the whole retina revealed
a modest, but statistically significant, protection of S-opsin+
and M/L-opsin+ cones in the creatine group compared to
the normal diet cohort (P < 0.05; P < 0.01, respectively,
by Student’s unpaired t-test; Figure 12Q). When the data
were subdivided into central (Figure 12R) and peripheral
(Figure 12S) regions, the same patterns were evident, but the
neuroprotective effect of creatine only reached significance in
the peripheral retina for each cone type (P < 0.01, by Student’s
unpaired t-test).
FIGURE 9 | Representative double labeling immunofluorescence images of
ubiquitous mitochondrial creatine kinase (CK-MT1A) with S-opsin in wild-type
mouse retina and Rd1 mouse retinas from postnatal day (P) 7 to P60. In WT
retinas (A–C) and at P7 (D–F), CK-MT1A colocalizes with S-opsin in
photoreceptor inner segments, cone somas, and axonal terminals. At P14,
the ONL is dramatically reduced in thickness. CK-MT1A colocalizes with
S-opsin in shrunken inner segments, cone somas, and axonal terminals (G–I).
From P21 onward, the ONL is reduced to a single layer of surviving cones
largely devoid of segments. CK-MT1A expression within S-opsin-positive
cone somas and axonal terminals persists at all time points (J–R). All images
were captured from the inferior retina, which comprises primarily S-cones.
INL, inner nuclear layer; IS, inner segments; ONL, outer nuclear layer. Scale
bar: 20 µm.
DISCUSSION
Targeting secondary cone degeneration is a broad-spectrum
strategy applicable to a large proportion of RP subtypes
irrespective of the primary gene defect. An increasing body
of evidence has implicated energetic insufficiency as a key
component of cone degeneration, and, in the present study,
we utilized in vitro and in vivo models of RP to explore
whether increasing the availability of two nutrients promotes
cone survival. Our results showed that glucose improved cone
survival in retinal cultures subjected to mitochondrial stress
or oxidative insult; however, daily subconjunctival injections of
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FIGURE 10 | Representative double labeling immunofluorescence images of
cytosolic creatine kinase (CK-B) with S-opsin in wild-type (WT) mouse retina
and in Rd1 mouse retinas from postnatal day (P) 14 to P60. In WT retinas
(A–C), CK-B colocalizes with S-opsin in cone inner segments (arrows), and in
axonal terminals in the outer plexiform layer (arrows). At P14, CK-B
colocalizes with S-opsin in shrunken inner segments and axonal terminals,
with weak CK-B labeling of somas (D–F). From P30 to P60, the ONL
comprises a single layer of surviving cones largely devoid of segments. CK-B
colocalizes with S-opsin in cone somas and axonal terminals (G–L). At all time
points, CK-B is also expressed by inner retinal neurons and Müller cells. All
images were captured from the inferior retina, which comprises primarily
S-cones. INL, inner nuclear layer; IS, inner segments; ONL, outer nuclear
layer. Scale bar: 20 µm.
glucose neither enhanced spatial visual performance nor slowed
cone cell degeneration in rd1 mice relative to isotonic saline.
In contrast, creatine not only promoted cone survival in retinal
cultures, but also improved vision and reduced cone degeneration
in rd1 mice. The results of this study provide tentative support
for the hypothesis that creatine supplementation may delay
secondary degeneration of cones in individuals with RP.
Glucose Supplementation for Cone
Survival
In order to mimic cone loss in vitro as a first step to
understanding the potential role of nutraceutical protection of
cones in situ, we established culture preparations in which cones
were present. Immunocytochemical labeling of these cultures
revealed a distinct population of small cells with dendrites,
but no obvious segments. In fact, photoreceptors within the
culture system employed lose their segments during the first
24 h in vitro. The absence of outer segments from otherwise
viable photoreceptor cells in similar mixed cultures has been
described previously (Gaudin et al., 1996). Our culture system
can thus be used to assess the survival of cones whose segments
have degenerated or are in the process of doing so. This model,
FIGURE 11 | Performance of Rd1 mice in the optomotor tracking test
undertaken at P30. Values represent mean ± SEM, where n = 18–21.
∗∗P < 0.01 by Student’s unpaired t-test (creatine-enriched diet vs. control
diet eyes).
therefore, is of direct relevance to RP, since degeneration of
segments is an early pathological event in RP.
We subjected cultures to metabolic disturbance (sodium
azide) and oxidative stress (tbH), each of which is implicated
in the pathology of cone loss in RP. In both scenarios,
concentration-dependent toxicity to S-opsin+-cones was noted
that was counteracted by pretreatment with glucose. Glucose has
been shown to protect against retinal cell loss induced by azide in
a previous in vitro study (Wood et al., 2012). Notably, however,
protection was greater to glia than inner retinal neurons, a finding
explained by the greater reliance of neurons on mitochondrial
metabolism. The degree of cone protection was similar to
that measured for inner retinal neurons previously, implying
that the metabolism, and mitochondrial reliance of these cell
types is analogous. It may seem that enhancing glycolysis
by supplementation with glucose would inevitably counteract
mitochondrial compromise, but this makes the assumption that
cell metabolism is plastic and can respond rapidly and efficiently
to altered energy demands and changing substrate supplies.
In the present study, cells are maintained with pyruvate and
glutamine, both of which are predominantly metabolized via
mitochondria-based pathways. When mitochondria are made
dysfunctional with azide, cells will die unless aerobic glycolysis
can be alternatively promoted; the addition of glucose offers that
possibility, but relies on the metabolic flexibility of the cells.
Since aerobic glycolysis contributes to photoreceptor metabolism
in situ (Chinchore et al., 2017), it is unsurprising that cones can
respond to mitochondrial disturbance in vitro.
The protective effect of glucose against induced oxidative
stress is highly unlikely to be mediated through a direct
antioxidative action. Instead, glucose is able to counteract
excessive oxidative stress by activation of the pentose phosphate
pathway, which produces NADPH to maintain cellular
glutathione levels (Ben-Yoseph et al., 1996). Glutathione
is the major intracellular antioxidant and maintenance of
its active reduced state occurs via the enzyme glutathione
reductase. Expression of this enzyme has been demonstrated
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FIGURE 12 | Effect of creatine supplementation on cone survival. (A–P) Photomicrographs of wholemount Rd1 retinas analyzed at postnatal day (P) 60
immunolabeled for S-opsin and M/L-opsin. Representative images from mice fed a creatine-enriched diet (A–D,I–L) or a normal diet (E–H,M–P) are shown. S-P,
superior-peripheral retina; S-C, superior-central retina; I-C, inferior-central retina; I-P, inferior-peripheral retina. Scale bar 100 µm. (Q–S) Quantification of
S-opsin-labeled cones and M/L-opsin-labeled cones in retinal wholemounts from Rd1 mice fed a creatine-enriched diet or a standard diet. Data are shown for the
whole retina (Q), subdivided into central (R), and peripheral (S) regions. Values, shown as % of control diet, represent mean ± SEM, where n = 18–21. ∗P < 0.05,
∗∗P < 0.01 by Student’s unpaired t-test (creatine vs. control eyes).
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in photoreceptors in situ (Fujii et al., 2001). This, then, is a key
action of glucose: maintaining control over oxidative attack via
stimulation of additional or alternate metabolic pathways.
Healthy photoreceptors display a high rate of aerobic
glycolysis (Chinchore et al., 2017). Accordingly, they express
a specific complement of glycolytic isoenzymes, including
hexokinase II, pyruvate kinase M2, and LDH-V, which are
concentrated in their inner segments (Casson et al., 2016;
Petit et al., 2018). The importance of hexokinase II for cone
homeostasis has recently been established in a study by Petit
et al. (2018), who showed that deletion of HK2 has minimal
impact upon cone viability in normal conditions, but, that
HK2 confers a survival advantage in cones under conditions
of metabolic stress. Since loss of cone segments is an early
pathological event in RP, we investigated whether surviving cones
in the Rd1 retina continue to express genes vital for aerobic
glycolysis. The data showed that, at all ages analyzed, cone
somas in the Rd1 retina expressed hexokinase II and LDH-
A (as well as PKM2 and neuron-specific enolase). The robust
labeling of hexokinase II and LDH-A in surviving cones testifies
to the fact that the biochemical machinery required for aerobic
glycolysis persists despite the irrevocable disruption to their
normal cellular architecture. Boosting energy supplies should
allow cones to survive for longer and may even facilitate the
process of segment regeneration, in an analogous manner to that
observed in experimental retinal detachment following oxygen
supplementation (Mervin et al., 1999).
The lack of protective effect of local glucose delivery in Rd1
mice may be due to a number of factors. The first issue to
consider is how much additional glucose is available for uptake
by cones. Subconjunctival injection is considerably less invasive
than intravitreal or subretinal injections, permitting daily
administration, and resulting in higher bioavailability than other
periocular injection sites; however, retinal bioavailability is lower
than intravitreal injection owing to the various barriers between
the sites of administration and the target (Del Amo et al., 2017).
In previous work, we showed that subconjunctival injection of
glucose elevated the vitreal glucose level and protected retinal
ganglion cells from ischemia-reperfusion (Shibeeb et al., 2016),
while in the present study, a single subconjunctival injection
of glucose resulted in >threefold elevation of the vitreous
glucose concentration. These data suggest that subconjunctivally
administered glucose likely reaches the photoreceptor layer;
however, it should be recognized that our earlier study featured
target neurons that reside closest to the vitreous humor, as
well as an acute, rather than chronic, model of injury. In the
Rd1 mouse, inner retinal neurons and glia would be exposed
to the glucose before it reaches the cones, reducing the total
amount delivered. To shed some light on this question, we
analyzed tissue sections of retina from wild type mouse eyes
that had undergone a subconjunctival injection of 2-NDBG, a
stable, fluorescent glucose derivative used for monitoring glucose
uptake into living cells. The data showed 2-NBDG fluorescence
within photoreceptor inner and outer segments, confirming
that at least some glucose reaches the photoreceptor layer after
subconjunctival injection. The pattern of 2-NBDG fluorescence
was similar to that reported after oral administration of the drug
in mice (Kanow et al., 2017). While these qualitative data verify
that glucose reaches cones after subconjunctival injection, they
do not reveal the concentration.
A second issue relates to timing. Whilst there was a substantial
increase in vitreal glucose after 1 h, the concentration decreased
quite rapidly thereafter. In a chronic model of degeneration,
controlled, slow release of drug is advantageous to ensure
continued bioavailability. In contrast to the subconjunctival
route, subretinal injection delivers glucose directly to cones, and
excitingly this methodology has been shown to cause a short-
term improvement in cone function as well as outer segment
synthesis when tested in the early stages of cone pathology in
the P23H porcine model of RP (Wang et al., 2016). Subretinal
injection is, however, technically challenging and only suited
to one-off applications such as delivery of genes or stem cells
(Del Amo et al., 2017).
An additional explanation for the lack of efficacy of glucose
on cone survival relates to reduced uptake of glucose into cones.
Extracellular glucose is believed to enter cones primarily via
GLUT1, although other uptake mechanisms may exist since
GLUT1 expression in cones appears to be very modest given the
extraordinarily high metabolic activity of these cells (Gospe et al.,
2010; Ait-Ali et al., 2015; Swarup et al., 2019). The activity of
GLUT1 is stimulated by a soluble factor released from rods (Ait-
Ali et al., 2015). In rd1 mice, rod death will result in less efficient
uptake of glucose into cones and reduced aerobic glycolysis. In
response, cones compensate by increasing synthesis of GLUT1
in a bid to increase intracellular glucose (Punzo et al., 2009;
Venkatesh et al., 2015). Thus, although more glucose may be
available for uptake after local delivery of glucose, this may not
translate to a higher intracellular concentration. Therapies that
target GLUT1 or its binding partner BSG-1 may need to be
employed (Ait-Ali et al., 2015). A final point worth making is
that, in our study, glucose supplementation began at P14 when
rod photoreceptors would still be present. It is possible that any
effects of glucose on cones were influenced by the presence of
rods. Glucose may conceivably have influenced the time course of
rod degeneration, but since retinas were not analyzed until P60,
this data is not available.
The finding that saline injections had a small beneficial
effect on visual function and cone survival was not entirely
unexpected. It has been proven that saline or dry needle injections
into the subretinal space provide a modest, but significant,
boost to photoreceptor survival in inherited or induced models
of degeneration via a mechanism of action hypothesized to
involve the release of survival factors (Faktorovich et al., 1990,
1992; Silverman and Hughes, 1990). It is likely that repeated
subconjunctival injections elicited an analogous response.
Creatine Supplementation for Cone
Survival
Creatine supplementation has been shown to be support
neuronal survival in a variety of animal models of
neurodegenerative disease, including Alzheimer’s disease
(Brewer and Wallimann, 2000), Parkinson’s disease (Matthews
et al., 1999), amyotrophic lateral sclerosis (Klivenyi et al., 1999),
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and Huntington’s disease (Matthews et al., 1998; Ferrante
et al., 2000; Andreassen et al., 2001). In the present study,
creatine supplementation protected cones against mitochondrial
compromise in vitro, and, improved visual function and cone
survival in rd1 mice.
The first important finding was that surviving cone
photoreceptors in rd1 mice continue to express creatine kinase.
Despite the loss of their mitochondrial-rich inner segments,
cone somas and axonal terminals in the rd1 retina were strongly
positive for both the mitochondrial and cytosolic forms of
creatine kinase at each time point examined. The data reveal
that the fundamental enzymes of the creatine-phosphocreatine
system are preserved in surviving cones of the rd1 retina and
attest to the logic of the neuroprotective strategy.
The cone protection afforded by creatine has several possible
mechanisms. Exogenous creatine supplementation has been
shown to increase the total intracellular phosphocreatine level
(Beal, 2011). Phosphocreatine provides energy to photoreceptor
outer segments for phototransduction and to synaptic terminals
for neurotransmission (Linton et al., 2010; Hurley et al., 2015).
Hence, creatine-induced cone preservation may simply result
from increasing the available phosphocreatine pool, thereby
supporting overall cellular energy production. Secondly, and
relatedly, mitochondrial creatine kinase is tightly coupled to
ATP synthesis, respiratory chain activity and ATP export. This
coupling improves the efficiency of oxidative phosphorylation,
and the transport and utilization of intracellular energy. Creatine
supplementation is believed to enhance these functions through
the action of creatine kinase (see Wallimann et al., 2011). In
the culture experiments outlined in the present study, creatine
was clearly protective against cone loss induced by mitochondrial
inhibition; this action could be explained by either of the
above mechanisms. Thirdly, numerous studies have shown that
exogenous creatine is highly effective at reducing cellular damage
caused by oxidative stress (see Wallimann et al., 2011). This
has been largely explained by the fact that creatine kinase
stabilizes mitochondrial membranes, reducing the release of
reactive oxygen species, although creatine is also a weak free
radical scavenger itself and has been shown to protect against
oxidative stress directly (Lawler et al., 2002). In the present
study, however, creatine was not able to protect cones in culture
from the effects of the tbH, thus dismissing the possibility of
it having a direct antioxidant mode of action in vitro. This
does not discount the possibility that creatine can act in an
indirect antioxidant capacity in situ, however, via a reduction
in mitochondrial release of free radicals. If this were the case,
then this is highly relevant to RP since an increasing body of
evidence implicates oxidative stress in the pathogenesis of cone
degeneration in the disease (Shen et al., 2005; Komeima et al.,
2006, 2007; Usui et al., 2009; Lee et al., 2011; Campochiaro
et al., 2015). Finally, creatine displays anti-apoptotic properties,
by virtue of inhibiting opening of the mitochondrial permeability
transition pore, and induction of differential expression of pro-
survival transcription factors and cell signaling pathways (see
Wallimann et al., 2011). Further investigation is needed to
definitively establish the precise mechanisms by which creatine
enhances cone survival in the rd1 mouse.
The major limitation of the present study is the early onset,
and fast progression, of cone degeneration in the rd1 model
of RP. Creatine supplementation was initiated at the time of
weaning, P21. By this age, however, all rod constituents and
the majority of cone outer segments had degenerated. rd1 mice
do not produce a recordable electroretinogram for many days
beyond P21 (Farber et al., 1994). The improvement observed
in the optokinetic response in creatine-fed mice suggests that
clinically useful visual function might be preserved even when
cone degeneration has progressed to a late stage. Nevertheless,
the use of a slower progressing model of degeneration, such as
the rd10 strain, would permit more expansive evaluation of cone
structure and function, including quantification of the rate of
cone segment loss, and measurement of the electroretinogram
(Wang et al., 2014).
The results of randomized clinical trials with oral creatine
supplementation for neurodegenerative diseases have largely
been disheartening to date. A number of clinical trials
investigating the efficacy of creatine in Parkinson’s disease all
failed to meet primary end points, despite some evidence of
improvements in secondary outcomes (Bender and Klopstock,
2016). Likewise, clinical outcomes in trials of creatine in
Huntingdon’s disease and Amyotrophic lateral sclerosis have also
been disappointing (Bender and Klopstock, 2016). Nevertheless,
there are convincing reasons for further investigation of
creatine in RP: firstly, creatine kinase is extremely abundant
in mammalian photoreceptors and appears to play a pivotal
role in vision (Linton et al., 2010); secondly, RP can be
diagnosed prior to secondary cone degeneration. From the
credible results of preclinical studies, it has been argued
that prophylactic treatment with creatine to prevent neuronal
degeneration is far more effective than treatment at later disease
stages; thirdly, there are no current therapies for RP and
any improvements in visual quality would be beneficial for
individuals; fourthly, the safety and ease of delivery of creatine
supplementation has been established and is clinically appealing,
although it must be recognized that adverse effects such as
gastrointestinal complaints, muscle cramps and an increase in
body weight have been reported to occur occasionally after
creatine supplementation (Andres et al., 2017). The development
of a targeted ocular delivery system, which bypasses the systemic
circulation, would potentially provide a safe, long-term route of
administration of even higher doses of creatine, which has shown
promise in individuals with premanifest Huntingdon’s disease
(Rosas et al., 2014).
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